Gain An Insight Into The Pipeline Status Of Melanoma Or Skin Cancer Drugs By Company And By Stage As Well As A Summary Of The Latest News And Developments In This Area
Posted on: Friday, 24 August 2007, 09:13 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c66622) has announced the addition of "Melanoma or Skin Cancer Drug Pipeline Report" to their offering.
"Melanoma or Skin Cancer Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of melanoma or skin cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits:
- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
Recent Highlights and Changes:
Melanoma or Skin Cancer Pipeline Overview
% of Projects (By Phase of Development)
No. of Projects by Phase of Development
Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
Legend
Top 20 companies in late stage Melanoma or Skin Cancer Projects
Top 20 companies in early stage Melanoma or Skin Cancer Projects
Full Pipeline View
Pre Clinical Pipeline View
Phase II Pipeline View
Phase III Pipeline View
For more information visit http://www.researchandmarkets.com/reports/c66622
Source: Life Science Analytics
Source: Business Wire
Related Articles
- Short-Term Hormone Therapy And Intermediate Dose Radiation Increases Survival For Early Stage Prostate Cancer
- Cangen Biotechnologies Inc. And Dai Nippon Printing Co., Ltd. Move Forward With Development Of An Early Stage Lung Cancer Diagnostic
- Node-Negative Early Stage Breast Cancer Patients Benefit From Taxotere(R)-Based Chemotherapy
- Phase II Results For Yale's Early Stage Ovarian Cancer Blood Test 99% Accurate
- Hollis-Eden Pharmaceuticals Announces Filing of IND With APOPTONE(TM) in Hormone Sensitive Cancers to Commence Phase I/II Clinical Trial in Late-Stage Prostate Cancer
- New Data Shows DAVANAT(R) Extends Survival of End-Stage Colorectal Cancer Patients More Than 6 Months
- UK Male Deaths from Melanoma Skin Cancer Rising Fast
- European Study Shows Promise of Intraoperative Radiation Therapy in Treatment of Early-Stage Breast Cancer
- Cell Genesys Reports Synergistic Antitumor Activity for GVAX(R) Cancer Vaccine and Anti-Angiogenesis Therapy in Preclinical Studies
- First International Registry of Patients With Early Stage Breast Cancer Launched
 |
 |
User Comments (0)
RSS Feeds